{{header
 | author     = Chris Gibson (New York politician)
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2014
 | month      = 05
 | day        = 21
 | notes      = ''{{USBill|113|H.R.|4701}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 2
 | title      = Tick-Borne Disease Research Accountability and Transparency Act of 2014 ( H.R. 4701; 113th Congress)
 | bill       = 4701
 | billtype   = hr
 | purpose    = To provide for scientific frameworks with respect to vector-borne diseases.
 | wikipedia  =
}}
      Union Calendar No. 424 
{{Center|113th CONGRESS}}

 
{{Center|2d Session}}

 
{{Center|H. R. 4701}}

 <nowiki>[Report No. 113–573]</nowiki> 
{{Center|IN THE HOUSE OF REPRESENTATIVES}}

  
{{Center|May 21, 2014}}

 
{{Center| 
[[w:Chris Gibson (New York politician)|Mr. Gibson]](for himself,
[[w:Joe Courtney (politician)|Mr. Courtney]],
[[w:Collin Peterson|Mr. Peterson]],
[[w:Chris Smith (New Jersey politician)|Mr. Smith of New Jersey]],
[[w:Frank Wolf (politician)|Mr. Wolf]], and
[[w:Lou Barletta|Mr. Barletta]]) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] }}

   
{{Center|September 8, 2014}}

 
{{Center|Additional sponsors:
[[w:Peter Welch|Mr. Welch]],
[[w:Sean Patrick Maloney|Mr. Sean Patrick Maloney of New York]],
[[w:Bill Posey|Mr. Posey]],
[[w:Rob Wittman|Mr. Wittman]],
[[w:Jan Schakowsky|Ms. Schakowsky]],
[[w:Elizabeth Esty|Ms. Esty]],
[[w:Leonard Lance|Mr. Lance]],
[[w:John Shimkus|Mr. Shimkus]],
[[w:Paul Tonko|Mr. Tonko]],
[[w:John Barrow (U.S. politician)|Mr. Barrow of Georgia]],
[[w:William R. Keating|Mr. Keating]],
[[w:Gerry Connolly|Mr. Connolly]],
[[w:Carol Shea-Porter|Ms. Shea-Porter]], and
[[w:Dan Maffei|Mr. Maffei]] }}

   
{{Center|September 8, 2014}}

 
{{Center|Reported with amendments, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed}}

 Strike out all after the enacting clause and insert the part printed in italic For text of introduced bill, see copy of bill as introduced on May 21, 2014   
{{Center|  }}

  
{{Center|A BILL}}

 To provide for scientific frameworks with respect to vector-borne diseases.    

=Section 1. Short title=

This Act may be cited as the“   Tick-Borne Disease Research Accountability and Transparency Act of 2014   ”. 

=Sec. 2. Lyme disease and other tick-borne diseases=

   Title III of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/241 42 U.S.C. 241 et seq.] )is amended by adding at the end the following new part:

<blockquote> 

==W Lyme disease and other tick-borne diseases– ==



==Sec. 399OO. Research==



===(a) In general– ===

The [[w:Department of Health and Human Services|Secretary]]shall conduct or support epidemiological, basic, translational, and clinical research regarding Lyme disease and other tick-borne diseases.

===(b) Biennial reports– ===

The [[w:Department of Health and Human Services|Secretary]]shall ensure that each biennial report under section 403 includes information on actions undertaken by the [[w:National Institutes of Health|National Institutes of Health]]to carry out subsection (a) with respect to Lyme disease and other tick-borne diseases, including an assessment of the progress made in improving the outcomes of Lyme disease and such other tick-borne diseases.

==Sec. 399OO–1. Working Group==



===(a) Establishment– ===

The [[w:Department of Health and Human Services|Secretary]]shall establish a permanent working group, to be known as the [[w:Department of Health and Human Services|Interagency Lyme and Tick-Borne Disease Working Group]](in this section and section 399OO–2 referred to as the“Working Group”), to review all efforts within the [[w:Department of Health and Human Services|Department of Health and Human Services]]concerning Lyme disease and other tick-borne diseases to ensure interagency coordination, minimize overlap, and examine research priorities.

===(b) Responsibilities– ===

The [[w:Department of Health and Human Services|Working Group]]shall—
:(1) not later than 24 months after the date of enactment of this part, and every 24 months thereafter, develop or update a summary of—
::(A) ongoing Lyme disease and other tick-borne disease research related to causes, prevention, treatment, surveillance, diagnosis, duration of illness, intervention, and access to services and supports for individuals with Lyme disease or other tick-borne diseases;
::(B) advances made pursuant to such research;
::(C) the engagement of the [[w:Department of Health and Human Services|Department of Health and Human Services]]with persons that participate at the public meetings required by paragraph (5) ; and
::(D) the comments received by the [[w:Department of Health and Human Services|Working Group]]at such public meetings and the [[w:Department of Health and Human Services|Secretary’s]]response to such comments;
:(2) ensure that a broad spectrum of scientific viewpoints is represented in each such summary;
:(3) monitor Federal activities with respect to Lyme disease and other tick-borne diseases;
:(4) make recommendations to the [[w:Department of Health and Human Services|Secretary]]regarding any appropriate changes to such activities; and
:(5) ensure public input by holding annual public meetings that address scientific advances, research questions, surveillance activities, and emerging strains in species of pathogenic organisms.

===(c) Membership– ===



====(1) In general– ====

The [[w:Department of Health and Human Services|Working Group]]shall be composed of a total of 14 members as follows:

=====(A) Federal members– =====

Seven Federal members, consisting of one or more representatives of each of—
:(i) the [[w:Surgeon General of the United States|Office of the Assistant Secretary for Health]];
:(ii) the [[w:Food and Drug Administration|Food and Drug Administration]];
:(iii) the [[w:Centers for Disease Control and Prevention|Centers for Disease Control and Prevention]];
:(iv) the [[w:National Institutes of Health|National Institutes of Health]]; and
:(v) such other agencies and offices of the [[w:Department of Health and Human Services|Department of Health and Human Services]]as the [[w:Department of Health and Human Services|Secretary]]determines appropriate.

=====(B) Non-Federal public members– =====

Seven non-Federal public members, consisting of representatives of the following categories:
:(i) Physicians and other medical providers with experience in diagnosing and treating Lyme disease and other tick-borne diseases.
:(ii) Scientists or researchers with expertise.
:(iii) Patients and their family members.
:(iv) Nonprofit organizations that advocate for patients with respect to Lyme disease and other tick-borne diseases.
:(v) Other individuals whose expertise is determined by the [[w:Department of Health and Human Services|Secretary]]to be beneficial to the functioning of the [[w:Department of Health and Human Services|Working Group]].

====(2) Appointment– ====

The members of the [[w:Department of Health and Human Services|Working Group]]shall be appointed by the [[w:Department of Health and Human Services|Secretary]], except that of the non-Federal public members under paragraph (1)(B) —
:(A) one shall be appointed by the [[w:United States House of Representatives|Speaker of the House of Representatives]]; and
:(B) one shall be appointed by the [[w:United States Senate|Majority Leader of the Senate]].

====(3) Diversity of scientific perspectives– ====

In making appointments under paragraph (2) , the [[w:Department of Health and Human Services|Secretary]], the [[w:United States House of Representatives|Speaker of the House of Representatives]], and the [[w:United States Senate|Majority Leader of the Senate]]shall ensure that the non-Federal public members of the [[w:Department of Health and Human Services|Working Group]]represent a diversity of scientific perspectives.

====(4) Terms– ====

The non-Federal public members of the [[w:Department of Health and Human Services|Working Group]]shall each be appointed to serve a 4-year term and may be reappointed at the end of such term.

===(d) Meetings– ===

The [[w:Department of Health and Human Services|Working Group]]shall meet as often as necessary, as determined by the [[w:Department of Health and Human Services|Secretary]], but not less than twice each year.

===(e) Reporting– ===

Not later than 24 months after the date of enactment of this part, and every 24 months thereafter, the [[w:Department of Health and Human Services|Working Group]]—
:(1) shall submit a report on its activities, including an up-to-date summary under subsection (b)(1) and any recommendations under subsection (b)(4) , to the [[w:Department of Health and Human Services|Secretary]], the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce of the House of Representatives]], and the [[w:United States Senate Committee on Health, Education, Labor, and Pensions|Committee on Health, Education, Labor and Pensions of the Senate]];
:(2) shall make each such report publicly available on the website of the [[w:Department of Health and Human Services|Department of Health and Human Services]]; and
:(3) shall allow any member of the [[w:Department of Health and Human Services|Working Group]]to include in any such report minority views.

==Sec. 399OO–2. Strategic plan==

Not later than 3 years after the date of enactment of this section, and every 5 years thereafter, the [[w:Department of Health and Human Services|Secretary]]shall submit to the [[w:United States Congress|Congress]]a strategic plan, informed by the most recent summary under section 399OO–1(b)(1) , for the conduct and support of Lyme disease and tick-borne disease research, including—
:(1) proposed budgetary requirements;
:(2) a plan for improving outcomes of Lyme disease and other tick-borne diseases, including progress related to chronic or persistent symptoms and chronic or persistent infection and co-infections;
:(3) a plan for improving diagnosis, treatment, and prevention;
:(4) appropriate benchmarks to measure progress on achieving the improvements described in paragraphs (2) and (3) ; and
:(5) a plan to disseminate each summary under section 399OO–1(b)(1) and other relevant information developed by the [[w:Department of Health and Human Services|Working Group]]to the public, including health care providers, public health departments, and other relevant medical groups. . 
</blockquote>
  Amend the title so as to read:“A bill to provide for research with respect to Lyme disease and other tick-borne diseases, and for other purposes.”.  
{{Center|September 8, 2014}}

 
{{Center|Reported with amendments, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed}}

  
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
